Ashley Ann Frazer-abel PhD

Dr. Frazer-Abel directs a laboratory at the University of Colorado Denver that focuses on complement analysis. The specialized testing utilized at Exsera advances novel research, as well as aiding in patient diagnoses and partnering in novel drug development. Currently, Exsera is engaged in optimizing assays to meet the testing requirements of the growing number of complement therapeutics in development.

Dr. Frazer-Abel has over a decade of experience in the area of complement analysis, including the development of a number of novel assays that have been successful in answering previously unmet diagnostic needs. She has also applied her complement expertise to acting as Principal Investigator for numerous non-clinical and clinical trials. Dr. Frazer-Abel was part of the first US laboratory to participate in the International Complement Society Committee on Complement Assay Improvement and Standardization. She continues to participate in that committee, currently as facilitator for the Activation Fragment Subcommittee.